7 results on '"Arbeev, Konstantin"'
Search Results
2. Uncoupling associations of risk alleles with endophenotypes and phenotypes: insights from the ApoB locus and heart-related traits.
- Author
-
Kulminski, Alexander M., Kernogitski, Yelena, Culminskaya, Irina, Loika, Yury, Arbeev, Konstantin G., Bagley, Olivia, Duan, Matt, Arbeeva, Liubov, Ukraintseva, Svetlana V., Wu, Deqing, Stallard, Eric, and Yashin, Anatoliy I.
- Subjects
UNCOUPLING proteins ,HEART aging ,APOLIPOPROTEIN B ,BIOLOGICAL evolution ,LOCUS (Genetics) ,DISEASE susceptibility ,GENETIC polymorphisms - Abstract
Traditionally, genomewide association studies ( GWAS) have emphasized the benefits of large samples in the analyses of age-related traits rather than their specific properties. We adopted a realistic concept of genetic susceptibility to inherently heterogeneous, age-related traits driven by the elusive role of evolution in their properties. We analyzed in detail the associations of rs693 and rs562338 polymorphisms representing the Apolipoprotein B locus with endophenotypes (total cholesterol [ TC] and high-density lipoprotein cholesterol) and phenotypes (myocardial infarction [ MI] and survival) in four large-scale studies, which include 20 748 individuals with 2357 MI events. We showed that a strong, robust predisposition of rs693 and rs562338 to TC (β = 0.72, P = 7.7 × 10
−30 for rs693 and β = −1.08, P = 9.8 × 10−42 for rs562338) is not translated into a predisposition to MI and survival. The rs693_A allele influences risks of MI and mortality after MI additively with lipids. This allele shows antagonistic effects-protecting against MI risks (β = −0.18, P = 1.1 × 10−5 ) or increasing MI risks (β = 0.15, P = 2.8 × 10−3 ) and mortality after MI, in different populations. Paradoxically, increased TC concentrations can be protective against MI for the rs693_A allele carriers. Our results uncouple the influences of the same alleles on endophenotypes and phenotypes despite potential causal relationships among the latter. Our strategy reveals virtually genomewide significance for the associations of rs693 with MI ( P = 5.5 × 10−8 ) that is contrasted with a weak estimate following the traditional, sample-size-centered GWAS strategy ( P = 0.16) in the same sample. These results caution against the use of the traditional GWAS strategy for gaining profound insights into genetic predisposition to healthspan and lifespan. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
3. The role of lipid-related genes, aging-related processes, and environment in healthspan.
- Author
-
Kulminski, Alexander M., Culminskaya, Irina, Arbeev, Konstantin G., Ukraintseva, Svetlana V., Stallard, Eric, Arbeeva, Liubov, and Yashin, Anatoli I.
- Subjects
LIPIDS ,AGING ,LIFE spans ,GENETIC polymorphisms ,ETIOLOGY of diseases ,GENETIC regulation - Abstract
The inherent complexity of aging-related traits can temper progress in unraveling the genetic origins of healthspan. We focus on two generations in the Framingham Heart Study, the original ( FHS) and offspring ( FHSO) cohorts, to determine whether aging-related processes in changing environments can substantially impact the role of lipid-related genes discovered in candidate gene (the apolipoprotein E ( APOE) e2/3/4 polymorphism) and genome-wide (the APOB rs1042034 (C/T)) studies, in regulation of total cholesterol ( TC) and onset of cardiovascular disease ( CVD). We demonstrate that the APOE e4 allele and APOB CC genotype can play detrimental, neutral, and protective sex-specific roles in the etiology of CVD at different ages and in different environments. We document antagonistic roles for the e4 allele in the onset of CVD characterized by detrimental effects at younger ages ( RR
≤ 75 years = 1.49, P = 7.5 × 10−4 ) and protective effects at older ages ( RR76+years = 0.77, P = 0.044) for FHS participants. We found that disregarding the role of aging erroneously nullifies the significant effects of the e4 allele in this sample ( RR = 0.92, P = 0.387). The leading biogenetic pathways mediating genetic effects on CVD may be more relevant to lipid metabolism for APOB than APOE. Aging-related processes can modulate the strength of genetic associations with TC in the same individuals at different chronological ages. We found substantial differences in the effects of the same APOE and APOB alleles on CVD and TC across generations. The results suggest that aging-related processes in changing environments may play key roles in the genetics of healthspan. Detailed systemic integrative analyses may substantially advance the progress. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
4. Effect of the APOE Polymorphism and Age Trajectories of Physiological Variables on Mortality: Application of Genetic Stochastic Process Model of Aging.
- Author
-
Arbeev, Konstantin G., Ukraintseva, Svetlana V., Kulminski, Alexander M., Akushevich, Igor, Arbeeva, Liubov S., Culminskaya, Irina V., Deqing Wu, and Yashin, Anatoliy I.
- Subjects
- *
CHOLESTEROL , *BLOOD pressure , *APOLIPOPROTEIN E , *GENETIC polymorphisms , *AGE factors in disease , *SEX factors in disease , *MORTALITY - Abstract
We evaluated effects of the APOE polymorphism (carriers versus noncarriers of the e4 allele) and age trajectories of total cholesterol (CH) and diastolic blood pressure (DBP) on mortality risk in the Framingham Heart Study (original cohort). We found that long-lived carriers and noncarriers have different average age trajectories and long-lived individuals have consistently higher levels and less steep declines at old ages compared to short-lived individuals. We applied the stochastic process model of aging aimed at joint analyses of genetic and nongenetic subsamples of longitudinal data and estimated different aging-related characteristics for carriers and noncarriers which otherwise cannot be evaluated from data. We found that such characteristics differ in carriers and noncarriers: (1) carriers have better adaptive capacity than noncarriers in case of CH, whereas for DBP the opposite situation is observed; (2) mean allostatic trajectories are higher in carriers and they differ from "optimal" trajectories minimizing mortality risk; (3) noncarriers have lower baseline mortality rates at younger ages but they increase faster than those for carriers resulting in intersection at the oldest ages. Such observations strongly indicate the presence of a genetic component in respective aging-related mechanisms. Such differences may contribute to patterns of allele- and sex-specific mortality rates. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF
5. Trade-off in the effects of the apolipoprotein E polymorphism on the ages at onset of CVD and cancer influences human lifespan.
- Author
-
Kulminski, Alexander M., Culminskaya, Irina, Ukraintseva, Svetlana V., Arbeev, Konstantin G., Arbeeva, Liubov, Wu, Deqing, Akushevich, Igor, Land, Kenneth C., and Yashin, Anatoli I.
- Subjects
APOLIPOPROTEIN E ,CARDIOVASCULAR diseases ,GENETIC polymorphisms ,GENETIC regulation ,LIFE spans ,CANCER genetics ,GENE frequency - Abstract
Progress in unraveling the genetic origins of healthy aging is tempered, in part, by a lack of replication of effects, which is often considered a signature of false-positive findings. We convincingly demonstrate that the lack of genetic effects on an aging-related trait can be because of trade-offs in the gene action. We focus on the well-studied apolipoprotein E ( APOE) e2/3/4 polymorphism and on lifespan and ages at onset of cardiovascular diseases (CVD) and cancer, using data on 3924 participants of the Framingham Heart Study Offspring cohort. Kaplan-Meier estimates show that the e4 allele carriers live shorter lives than the non-e4 allele carriers (log rank = 0.016). The adverse effect was attributed to the poor survival of the e4 homozygotes, whereas the effect of the common e3/4 genotype was insignificant. The e3/4 genotype, however, was antagonistically associated with onsets of those diseases predisposing to an earlier onset of CVD and a later onset of cancer compared to the non-e4 allele genotypes. This trade-off explains the lack of a significant effect of the e3/4 genotype on survival; adjustment for it in the Cox regression model makes the detrimental effect of the e4 allele highly significant ( P = 0.002). This trade-off is likely caused by the lipid-metabolism-related (for CVD) and nonrelated (for cancer) mechanisms. An evolutionary rationale suggests that genetic trade-offs should not be an exception in studies of aging-related traits. Deeper insights into biological mechanisms mediating gene action are critical for understanding the genetic regulation of a healthy lifespan and for personalizing medical care. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
6. Association between APOE ϵ2/ϵ3/ϵ4;4 polymorphism and disability severity in a national long-term care survey sample.
- Author
-
Kulminski, Alexander, Ukraintseva, Svetlana V., Arbeev, Konstantin G., Manton, Kenneth G., Oshima, Junko, Martin, George M., and Yashin, Anatoli I.
- Subjects
APOLIPOPROTEIN E ,GENETIC polymorphisms ,MORTALITY ,GENETIC research ,LONGEVITY - Abstract
Background: early studies reported controversial findings on association of apolipoprotein E (APOE) polymorphism with disability. Objective: to analyse sex-specific associations of APOE genotypes with impairments in (instrumental) activities of daily living [(I)ADL] and mortality. Design: population-based 1999 National Long Term Care Survey (NLTCS) of the US older (65+) individuals. Participants: genetic data are available for 1,805 individuals. Methods: each of six genotypes of three common alleles of the APOE locus (ε2, ε3 and ε4) was tested on the association with a disability index or mortality. Results: APOE ε3/ε3 genotype significantly decreases odds ratio (OR) for IADL disability in males [OR = 0.48; 95% Confidence Interval (Cl) 0.31-0.76] while it exhibits no association in females. The OR for ADL disability is 0.19 (CI 0.04-0.99) for ε4/ε4 female carriers. The ε2/ε3 genotype increases the chances of TADL disability for males (OR = 2.33; CI 1.28-4.25). No significant association between APOE polymorphism and mortality was found. A surprising observation was that ε4/ε4 female carriers have a 5.3 times lower chance of having ADL disability than non-ε4/ε4-carriers. Conclusions: association of the APOE polymorphism with disability and lack of association with mortality support the view that APOE gene actions may be more significant as modulators of frailty than of longevity. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
7. Independent associations of TOMM40 and APOE variants with body mass index.
- Author
-
Kulminski, Alexander M., Loika, Yury, Culminskaya, Irina, Huang, Jian, Arbeev, Konstantin G., Bagley, Olivia, Feitosa, Mary F., Zmuda, Joseph M., Christensen, Kaare, and Yashin, Anatoliy I.
- Subjects
ALZHEIMER'S disease ,BODY weight ,BODY mass index ,GENOTYPES ,GENETIC polymorphisms - Abstract
The TOMM40‐APOE variants are known for their strong, antagonistic associations with Alzheimer's disease and body weight. While a stronger role of the APOE than TOMM40 variants in Alzheimer's disease was suggested, comparative contribution of the TOMM40‐APOE variants in the regulation of body weight remains elusive. We examined additive effects of rs2075650 and rs157580 TOMM40 variants and rs429358 and rs7412 APOE variants coding the ε2/ε3/ε4 polymorphism on body mass index (BMI) in age‐aggregated and age‐stratified cohort‐specific and cohort‐pooled analysis of 27,863 Caucasians aged 20–100 years from seven longitudinal studies. Minor alleles of rs2075650, rs429358, and rs7412 were individually associated with BMI (β = −1.29, p = 3.97 × 10−9; β = −1.38, p = 2.78 × 10−10; and β = 0.58, p = 3.04 × 10−2, respectively). Conditional analysis with rs2075650 and rs429358 identified independent BMI‐lowering associations for minor alleles (β = −0.63, p = 3.99 × 10−2 and β = −0.94, p = 2.17 × 10−3, respectively). Polygenic mega‐analysis identified additive effects of the rs2075650 and rs429358 heterozygotes (β = −1.68, p = 3.00 × 10−9), and the strongest BMI‐lowering association for the rs2075650 heterozygous and rs429358 minor allele homozygous carriers (β = −4.11, p = 2.78 × 10−3). Conditional analysis with four polymorphisms identified independent BMI‐lowering (rs2075650, rs157580, and rs429358) and BMI‐increasing (rs7412) associations of heterozygous genotypes with BMI. Age‐stratified conditional analysis revealed well‐powered support for a differential and independent association of the rs429358 heterozygote with BMI in younger and older individuals, β = 0.58, 95% confidence interval (CI) = −1.18, 2.35, p = 5.18 × 10−1 for 3,068 individuals aged ≤30 years and β = −4.28, CI = −5.65, −2.92, p = 7.71 × 10−10 for 6,052 individuals aged >80 years. TOMM40 and APOE variants are independently and additively associated with BMI. The APOE ε4‐coding rs429358 polymorphism is associated with BMI in older individuals but not in younger individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.